DK1082304T3 - Ny krystallinsk polymorf form af 1-methyl-5-p-toluoylpyrrol-2-acetamideddikesyre guaiacylester (MED 15) - Google Patents

Ny krystallinsk polymorf form af 1-methyl-5-p-toluoylpyrrol-2-acetamideddikesyre guaiacylester (MED 15)

Info

Publication number
DK1082304T3
DK1082304T3 DK98962664T DK98962664T DK1082304T3 DK 1082304 T3 DK1082304 T3 DK 1082304T3 DK 98962664 T DK98962664 T DK 98962664T DK 98962664 T DK98962664 T DK 98962664T DK 1082304 T3 DK1082304 T3 DK 1082304T3
Authority
DK
Denmark
Prior art keywords
toluoylpyrrole
methyl
ester
guaiacetic
med
Prior art date
Application number
DK98962664T
Other languages
English (en)
Inventor
Sergio Anzalone
Original Assignee
Medosan Ind Biochimi
Sigma Tau Ind Farmaceuti
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Medosan Ind Biochimi, Sigma Tau Ind Farmaceuti filed Critical Medosan Ind Biochimi
Application granted granted Critical
Publication of DK1082304T3 publication Critical patent/DK1082304T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/30—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D207/32—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D207/323—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms with only hydrogen atoms or radicals containing only hydrogen and carbon atoms directly attached to the ring nitrogen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pain & Pain Management (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Rheumatology (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pyrrole Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Peptides Or Proteins (AREA)
DK98962664T 1997-12-24 1998-12-16 Ny krystallinsk polymorf form af 1-methyl-5-p-toluoylpyrrol-2-acetamideddikesyre guaiacylester (MED 15) DK1082304T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT97RM000811A IT1297140B1 (it) 1997-12-24 1997-12-24 Forma cristallina del guaiacil estere dell'acido l-metil-5-p-toluoil- pirrol-2-acetammidoacetico, procedimento per la sua preparazione e
PCT/IT1998/000363 WO1999033797A1 (en) 1997-12-24 1998-12-16 NEW CRYSTALLINE POLYMORPHIC FORM OF 1-METHYL-5-p-TOLUOYLPYRROLE-2-ACETAMIDOACETIC ACID GUAIACYL ESTER (MED 15)

Publications (1)

Publication Number Publication Date
DK1082304T3 true DK1082304T3 (da) 2004-04-05

Family

ID=11405418

Family Applications (1)

Application Number Title Priority Date Filing Date
DK98962664T DK1082304T3 (da) 1997-12-24 1998-12-16 Ny krystallinsk polymorf form af 1-methyl-5-p-toluoylpyrrol-2-acetamideddikesyre guaiacylester (MED 15)

Country Status (22)

Country Link
US (1) US6288241B1 (da)
EP (1) EP1082304B1 (da)
JP (1) JP4693236B2 (da)
KR (1) KR100554704B1 (da)
CN (1) CN1200930C (da)
AT (1) ATE255562T1 (da)
AU (1) AU781283B2 (da)
BR (1) BR9814476A (da)
CA (1) CA2315835C (da)
CZ (1) CZ297132B6 (da)
DE (1) DE69820301T2 (da)
DK (1) DK1082304T3 (da)
ES (1) ES2210853T3 (da)
HK (1) HK1035717A1 (da)
HU (1) HU228112B1 (da)
IL (1) IL136828A (da)
IT (1) IT1297140B1 (da)
PL (1) PL197768B1 (da)
PT (1) PT1082304E (da)
SK (1) SK284777B6 (da)
TR (1) TR200001867T2 (da)
WO (1) WO1999033797A1 (da)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2020175023A1 (ja) * 2019-02-28 2020-09-03 国立大学法人東京工業大学 アミドの製造方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1210673B (it) * 1982-02-26 1989-09-20 Medosan Ind Biochimi Antinfiammatoria amidi pirrolacetiche ad attivita'
IT1148117B (it) * 1982-03-05 1986-11-26 Medosan Ind Biochimi Attivita'antiflogistica,analgesica,antipiretica,mucolitica e seda tiva della tosse dell'1 metil-5-p-tolilpirrol-2-acetato di 2'metossi-fenile
IT1197688B (it) * 1983-07-29 1988-12-06 Medosan Ind Biochimi Attivita' antiflogistica,analgesica,antipiretica ed antiaggregante piastrinica di 1-metil-5-metilbenzoilpirrol-2-acetamido acetanilidi
IT1278144B1 (it) * 1995-07-14 1997-11-17 Medosan Ricerca Srl Impiego dell'amtolmetineguacil (med 15) come farmaco antisecretivo sulla secrezione gastrica e quindi gastroprotettivo.
WO1999007363A1 (en) * 1997-08-08 1999-02-18 Medosan, Ricerca S.R.L. Use of the compound 2-methoxyphenyl-1-methyl-5p-methylbenzoyl-pyrrol-2-acetamido acetate for the production of an anti-inflammatory drug with prevention of gastric hypersecretion and renal impairment

Also Published As

Publication number Publication date
SK284777B6 (sk) 2005-11-03
HUP0101025A1 (hu) 2001-08-28
WO1999033797A1 (en) 1999-07-08
BR9814476A (pt) 2000-10-10
HUP0101025A3 (en) 2001-09-28
JP4693236B2 (ja) 2011-06-01
ES2210853T3 (es) 2004-07-01
EP1082304A1 (en) 2001-03-14
IL136828A0 (en) 2001-06-14
US6288241B1 (en) 2001-09-11
DE69820301D1 (de) 2004-01-15
AU781283B2 (en) 2005-05-12
KR20010033497A (ko) 2001-04-25
CA2315835C (en) 2008-03-25
SK8952000A3 (en) 2000-12-11
ATE255562T1 (de) 2003-12-15
HK1035717A1 (en) 2001-12-07
DE69820301T2 (de) 2004-10-14
CZ20002336A3 (cs) 2000-12-13
EP1082304B1 (en) 2003-12-03
TR200001867T2 (tr) 2000-12-21
PL197768B1 (pl) 2008-04-30
CA2315835A1 (en) 1999-07-08
AU1782899A (en) 1999-07-19
CN1200930C (zh) 2005-05-11
IT1297140B1 (it) 1999-08-03
CN1283185A (zh) 2001-02-07
KR100554704B1 (ko) 2006-02-24
ITRM970811A1 (it) 1999-06-24
CZ297132B6 (cs) 2006-09-13
HU228112B1 (en) 2012-11-28
JP2001527064A (ja) 2001-12-25
PT1082304E (pt) 2004-04-30
IL136828A (en) 2005-08-31
PL341424A1 (en) 2001-04-09

Similar Documents

Publication Publication Date Title
DK0876131T3 (da) Sammensætninger til lægemiddelindgivelse til forbedret stabilitet af androgener
EE200100246A (et) Asendatud fenüültsükloheksüülühendite uued esterderivaadid
ES2158537T3 (es) Derivados de acidos ciclopropilalcanoicos.
AR014349A1 (es) Proceso para la preparacion de [2-(2-tienil)etilamino](2-halogenofenil) acetatos de metilo racemicos u opticamente activos.
AU6075294A (en) Peptide analogs as irreversible interleukin-beta protease inhibitors
ATE211732T1 (de) N-benzylpiperidin- und tetrahydropyridin-derivate
GB9718903D0 (en) Method,compositions and kits for increasing the oral bioavailability of pharmaceutical agents
BR9912010A (pt) Polimorfo de um produto farmacêutico
HRP20030983B1 (en) Pharmaceutical composition comprising a lipase inhibitor and a sucrose fatty acid ester
HUP9903459A2 (hu) Oxa- és tiabiciklo[3.1.0]hexán-karbonsavak, eljárás előállításukra és ezeket tartalmazó gyógyszerkészítmények
PT736029E (pt) Sulfamatos de pseudofructopiranose anticonvulsivos
EA199800155A1 (ru) Новое соединение
DK1082304T3 (da) Ny krystallinsk polymorf form af 1-methyl-5-p-toluoylpyrrol-2-acetamideddikesyre guaiacylester (MED 15)
FR2768734B1 (fr) Nouveaux composes tricycliques, leur procede de preparation et les intermediaires de ce procede, leur application a titre de medicaments et les compositions pharmaceutiques les renfermant
ATE165083T1 (de) N-arylalkylphenylacetamidderivate
AU7470098A (en) Antithrombotic agents
DK0937057T3 (da) Hidtil ukendte (-)-enantiomerer af cis-3,4-chromanderivater anvendelige i forebyggelse eller behandling af østrogenrelaterede sygdomme eller syndromer
WO1998014454A3 (en) (o-ACYL-p-N-ACYLAMINO-PHENYL)-O-PHOSPHOETHANOLAMINES
NO20012266D0 (no) Fremgangsmåte for fremstilling av L-DOPA-etylester
NO993845D0 (no) Fremgangsmåte for fremstilling av smörsyrederivater
IT8421609A0 (it) Estere dell'acido (+)6-metossi-alfa-metil-2-naftalenacetico avente attivita'mucosecretolitica, antinfiammatoria, analgesica, antipiretica, procedimento per lasua preparazione e sue composizioni farmaceutiche.
BR9910603A (pt) Método aprimorado paraa preparar derivados de norbenzomorfano valiosos farmaceuticamente
IT1190663B (it) Composto ad attivita' antiinfiammatoria,analgesica e mucoregolatrice,procedimento per la sua preparazione e relative composizioni farmaceutiche
DK0971919T3 (da) Fremgangsmåde til fremstilling af 4H-4-oxo-quinolizin-3-carboxylsyrederivater
ID27591A (id) Proses pembuatan isoprop l-metil-[2-(3-n-propoksi-fenoksi) etil] amina